Reuters logo
BRIEF-GSK says early dolutegravir trial data encouraging
March 7, 2013 / 7:12 AM / 5 years ago

BRIEF-GSK says early dolutegravir trial data encouraging

LONDON, March 7 (Reuters) - GlaxoSmithKline Plc : * Dolutegravir sailing study in hiv announced * At 24 weeks, 79 percent of dolutegravir participants virologically suppressed

versus 70 percent on raltegravir * Says encouraging early data in dolutegravir sailing study

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below